The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
May. 01, 2018

Filed:

Aug. 02, 2013
Applicant:

Shire Pharmaceuticals Ireland Limited, Dublin, IE;

Inventors:

Jens Fogh, Lynge, DK;

Claes Andersson, Taby, SE;

Cecilia Weigelt, Stockholm, SE;

Christer Moller, Tullinge, SE;

Pia Hyden, Stocksund, SE;

Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
C12N 9/16 (2006.01); C12N 15/00 (2006.01); A61K 38/46 (2006.01); C07H 21/04 (2006.01); A61K 38/00 (2006.01);
U.S. Cl.
CPC ...
C12N 9/16 (2013.01); C12Y 301/06008 (2013.01); A61K 38/00 (2013.01);
Abstract

The present invention pertains to a process for production of recombinant arylsulfatase A in a cell culture system, the process comprising culturing a mammalian cell capable of producing rASA in liquid medium in a system comprising one or more bio-reactors; and concentrating, purifying and formulating the rASA by a purification process comprising one or more steps of chromatography. Other aspects of the invention provides a pharmaceutical composition comprising rASA, which is efficiently endocytosed via the mannose-6-phosphate receptor pathway in vivo as well as a rhASA a medicament and use of a rhASA for the manufacture of a medicament for reducing the galactosyl sulphatide levels within target cells in the peripheral nervous system and/or within the central nervous system in a subject. A final aspect of the invention provides a method of treating a subject in need thereof, said method comprising administering to said subject a pharmaceutical composition comprising a rhASA and thereby obtaining a reduction in the galactosyl sulphatide levels in target cells within said subject.


Find Patent Forward Citations

Loading…